Transapical Transcatheter Treatment of a Stenosed Aortic Valve Bioprosthesis Using the Edwards SAPIEN Transcatheter Heart Valve

Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Grou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of thoracic surgery 2009-06, Vol.87 (6), p.1943-1946
Hauptverfasser:	Klaaborg, Kaj-Erik, MD, Egeblad, Henrik, MD, Jakobsen, Carl-Johan, MD, Terp, Kim, MD, Lindskov, Christian, MD, Andersen, Henning Rud, MD, Thuesen, Leif, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Aortic Valve Stenosis - surgery Biological and medical sciences Bioprosthesis Cardiac Catheterization Cardiology. Vascular system Cardiothoracic Surgery Female Heart Valve Prosthesis Humans Medical sciences Pneumology Postoperative Complications - surgery Prosthesis Design Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).
ISSN:	0003-4975 1552-6259
DOI:	10.1016/j.athoracsur.2008.11.034